# The Optimization of Bioavailability From Iron Supplements: Study 2

> **NCT02177851** · NA · COMPLETED · sponsor: **Swiss Federal Institute of Technology** · enrollment: 20 (actual)

## Conditions studied

- Iron Deficiency
- Anemia
- Iron Deficiency Anemia

## Interventions

- **DIETARY_SUPPLEMENT:** Single oral iron dose of 120 mg per day for 3 consecutive days
- **DIETARY_SUPPLEMENT:** Two oral iron doses of 60 mg per day (morning + afternoon) for 3 consecutive days

## Key facts

- **NCT ID:** NCT02177851
- **Lead sponsor:** Swiss Federal Institute of Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02177851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02177851, "The Optimization of Bioavailability From Iron Supplements: Study 2". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT02177851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*